AU8785591A - Substituted azoles, process for their preparation, agents containing them and their use - Google Patents

Substituted azoles, process for their preparation, agents containing them and their use

Info

Publication number
AU8785591A
AU8785591A AU87855/91A AU8785591A AU8785591A AU 8785591 A AU8785591 A AU 8785591A AU 87855/91 A AU87855/91 A AU 87855/91A AU 8785591 A AU8785591 A AU 8785591A AU 8785591 A AU8785591 A AU 8785591A
Authority
AU
Australia
Prior art keywords
preparation
agents containing
substituted azoles
azoles
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU87855/91A
Inventor
Hermann Gerhards
Heinz-Werner Kleemann
Bernward Scholkens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU8785591A publication Critical patent/AU8785591A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU87855/91A 1990-11-16 1991-11-15 Substituted azoles, process for their preparation, agents containing them and their use Abandoned AU8785591A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4036645 1990-11-16
DE4036645A DE4036645A1 (en) 1990-11-16 1990-11-16 SUBSTITUTED AZOLE, METHOD FOR THE PRODUCTION THEREOF, THE AGENT, AND THEIR USE THEREOF

Publications (1)

Publication Number Publication Date
AU8785591A true AU8785591A (en) 1992-05-21

Family

ID=6418438

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87855/91A Abandoned AU8785591A (en) 1990-11-16 1991-11-15 Substituted azoles, process for their preparation, agents containing them and their use

Country Status (17)

Country Link
EP (1) EP0485929A1 (en)
JP (1) JPH04283569A (en)
KR (1) KR920009802A (en)
CN (1) CN1061410A (en)
AU (1) AU8785591A (en)
BR (1) BR9104948A (en)
CA (1) CA2055636A1 (en)
CS (1) CS347091A3 (en)
DE (1) DE4036645A1 (en)
FI (1) FI915381A (en)
HU (1) HUT59673A (en)
IE (1) IE913991A1 (en)
IL (1) IL100058A0 (en)
MX (1) MX9102098A (en)
NO (1) NO914481L (en)
PT (1) PT99521A (en)
ZA (1) ZA919059B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4036706A1 (en) * 1990-11-17 1992-05-21 Hoechst Ag METHOD FOR THE TREATMENT OF CARDIALS AND VASCULAR HYPERTROPHY AND HYPERPLASIA
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
DE4200954A1 (en) * 1991-04-26 1992-10-29 Bayer Ag New heterocycle-substd. phenylacetic acid derivs. - are angiotensin II antagonists for treating arterial hypertonia, atherosclerosis, coronary insufficiency, ischaemic cerebral disorders, respiratory disorders, etc.
JP3501484B2 (en) * 1992-12-17 2004-03-02 三共株式会社 Biphenyl derivative
US5300668A (en) * 1993-03-10 1994-04-05 Pfizer Inc. Certain esters of 1-(4-X-methylphenyl)cyclopent-3-ene-1-carboxylic acid, wherein X is a trialkylsilyloxy, bromo or hydroxy group, as intermediates
DE19645313A1 (en) 1996-11-04 1998-05-07 Basf Ag Substituted 3-benzylpyrazoles
SE9903028D0 (en) 1999-08-27 1999-08-27 Astra Ab New use
PE20070404A1 (en) 2005-07-29 2007-05-10 Wyeth Corp COMPOUNDS DERIVED FROM CYANOPYRROL-SULFONAMIDE AS MODULATORS OF THE PROGESTERONE RECEPTOR
PE20070182A1 (en) 2005-07-29 2007-03-06 Wyeth Corp CYANOPYRROL-PHENYL AMIDE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (en) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER and OTHER DISORDERS.
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
CN115557898B (en) * 2021-07-01 2024-08-20 诸葛国琴 Imidazole compound, intermediate and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1329614C (en) * 1987-05-02 1994-05-17 Rainer Buerstinghaus N-substituted azoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids

Also Published As

Publication number Publication date
CN1061410A (en) 1992-05-27
PT99521A (en) 1992-09-30
KR920009802A (en) 1992-06-25
IE913991A1 (en) 1992-05-20
CS347091A3 (en) 1992-06-17
ZA919059B (en) 1992-07-29
BR9104948A (en) 1992-06-23
CA2055636A1 (en) 1992-05-17
HUT59673A (en) 1992-06-29
FI915381A (en) 1992-05-17
IL100058A0 (en) 1992-08-18
DE4036645A1 (en) 1992-05-21
MX9102098A (en) 1992-07-08
EP0485929A1 (en) 1992-05-20
NO914481L (en) 1992-05-18
FI915381A0 (en) 1991-11-14
JPH04283569A (en) 1992-10-08
HU913583D0 (en) 1992-01-28
NO914481D0 (en) 1991-11-15

Similar Documents

Publication Publication Date Title
EP0468372A3 (en) Substituted azoles, process for their preparation and their use
AU2356888A (en) Substituted azoles and azines, processes for their preparation and their use as herbicides
EP0430881A3 (en) Photochromic compounds, process for their preparation and their use
ZA927305B (en) Substituted 4-akoxypyrimidines, process for their preparation, agents containing them, and their use as pesticides.
EP0407899A3 (en) Aminopyrimidine derivatives, process for their preparation, agent containing them and their use as fungicides
AP9300579A0 (en) New substituted pyrazole derivatives,process for their preparation and their use as herbicides
AU8785591A (en) Substituted azoles, process for their preparation, agents containing them and their use
IL106395A0 (en) 4-benzoxylisoxazole derivatives,process for their preparation and herbicidal compositions containing them
VN274A1 (en) 4-benzoylisoxazole compositions, process for preparing thereof, herbicide containing thereof and their use
HU9401691D0 (en) 2-oximino-2-phenyl-acetamide derivatives, process for their preparation, their use and fungicidal compositions containing them
AU1446688A (en) New 2-acylpyrrolidine derivatives, a process for the preparation thereof, agents containing them, and their use
HUP9900968A3 (en) Herbicidal substituted 3-aryl-pyrazoles, compositions containing them, method for their use and process for preparing the compounds
HUT69056A (en) Cyclic-acetals, process for their preparation and their use as herbicides
AU8251591A (en) Novel pyrrolobenzimidazoles, imidazobenzoxazinones and imidazoquinolones, process for their preparation and their use and preparations containing the compounds
AU4172693A (en) Novel thienothiazine derivatives, process for their preparation and their use
EP0533056A3 (en) Substituted aminopropanes, process for their preparation and their use as antimycotic agents
AU624746B2 (en) Process for the preparation of 5-amino-3-chlorosulfonyl-1,2,4-triazole
ZA908958B (en) Pyrimidine derivatives,process for their preparation,agents containing them and their use as fungicides
AU5220893A (en) Substituted N-hydroxycinnamamides, processes for their preparation, compositions containing them, and their use
EP0473267A3 (en) Acylaminopyridinecarboxamides, process for their preparation and their use as fungicides
IL98832A0 (en) Acylaminobenzamide derivatives,process for their preparation and fungicidal compositions containing them
AU8931591A (en) Pyridyl-pyrimidin-derivates, process for producing the same, agents containing the same and their use as fungicides
AU6886891A (en) Pyridine derivatives, process for making them, agents containing them and their use as fungicides
IL90004A0 (en) 5-fluoromethyl pyrimidine-2-sulfonamides,process for their preparation and composition for their use as herbicides
AU643161B1 (en) Novel azole derivatives, process for preparing the same and antimycotic-and antiaromatase-agents containing them